Dry Powder Inhaler Monodose RS01

Patented, manufactured, and marketed by Plastiape, the RS01 Monodose Dry Powder Inhaler has a refined piercing unit design, which required the study of new manufacturing techniques and a different assembly sequence in comparison with the older devices. The very robust design process fully achieved its target of identifying and preventing any possible causes of failure, mainly thanks to the inclusion of a fully automated control of all critical functions directly into the assembly lines. Tens of millions of units have already been successfully delivered to the worldwide market. Download this free whitepaper to find technical information about the Dry Powder inhaler Monodose RS01.

More About This Company